PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STARTING SECOND/THIRD-LINE THERAPY AND NOT RECEIVING A STEM CELL TRANSPLANT
C. R. Flowers,
J. M. Burke,
M. Vukcevic,
S. Snodgrass,
K. Saverno,
M. A. A. Lumiqued
Affiliations
C. R. Flowers
1 Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston
J. M. Burke
2 US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, United States of America
M. Vukcevic
3 MorphoSys AG, Planegg, Germany
S. Snodgrass
4 Incyte Corporation, Wilmington, United States of America
K. Saverno
4 Incyte Corporation, Wilmington, United States of America
